Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 11-20 of 69 for

Edit search filters
  1. A Study Comparing The Effectiveness And Safety Of Combining Three Versus Two Oral Treatments For The Initial Therapy Of Patients Who Have Newly Diagnosed Hypertension Of The Pulmonary Artery

    Jacksonville, FL

  2. Clinical Study To Assess The Efficacy And Safety Of Macitentan In Patients With Pulmonary Hypertension After Left Ventricular Assist Device Implantation

    Rochester, MN

  3. A Study Of Sotatercept For The Treatment Of Cpc-PH Due To HFpEF (MK-7962-007/​A011-16)

    Jacksonville, FL

  4. Open-label Extension Study Of GB002 In Adult Subjects With Pulmonary Arterial Hypertension (PAH)

    Jacksonville, FL

  5. SYMPHONY: A Study Of Macitentan In Pulmonary Arterial Hypertension To Validate The PAH-SYMPACT

    Scottsdale/Phoenix, AZ

  6. An Outcome Study Assessing A 75 Milligrams (Mg) Dose Of Macitentan To Treat Patients With Pulmonary Arterial Hypertension

    Scottsdale/Phoenix, AZ

  7. An Extension Study For Participants In LIQ861 Trials To Evaluate The Long-term Safety Of Dry Powder Inhalation Of Treprostinil

    Rochester, MN

  8. A Study Evaluating The Long-Term Efficacy And Safety Of Ralinepag In Subjects With PAH Via An Open-Label Extension

    Jacksonville, FL

  9. A Study Of Oral Levosimendan In Pulmonary Hypertension With Heart Failure With Preserved Left Ventricular Ejection Fraction

    Rochester, MN

  10. A Study of Treprostinil to Treat Interstitial Lung Disease Pulmonary Hypertension

    Rochester, MN

.

Mayo Clinic Footer